Viromed Medical AG Asset Resilience Ratio
Viromed Medical AG asset resilience ratio. Viromed Medical AG (Q11) has an Asset Resilience Ratio of 2.49% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Viromed Medical AG (Q11) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Viromed Medical AG (None–None)
Asset resilience ratio of Viromed Medical AG from None to None. This chart shows how Viromed Medical AG's Asset Resilience Ratio has changed over time. Read Viromed Medical AG balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Viromed Medical AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Viromed Medical AG.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €8.43 Million | 2.49% |
| Total Liquid Assets | €8.43 Million | 2.49% |
Asset Resilience Insights
- Limited Liquidity: Viromed Medical AG maintains only 2.49% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Viromed Medical AG Industry Peers by Asset Resilience Ratio
Compare Viromed Medical AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Contango ORE Inc
NYSE MKT:CTGO |
Gold | 0.00% |
|
Barrick Mining Corporation
NYSE:B |
Gold | 13.03% |
|
Gold Fields Ltd ADR
NYSE:GFI |
Gold | 11.69% |
|
AngloGold Ashanti Ltd
JSE:ANG |
Gold | 13.83% |
|
Gold Fields Ltd
JSE:GFI |
Gold | 11.83% |
|
Alamos Gold Inc
TO:AGI |
Gold | 8.52% |
|
Equinox Gold Corp
TO:EQX |
Gold | 1.42% |
|
De Grey Mining Ltd
AU:DEG |
Gold | 57.44% |
Viromed Medical AG Asset Resilience Ratio by Year (None–None)
Viromed Medical AG asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Viromed Medical AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Viromed Medical AG
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.